The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nectin-4 expression in primary breast cancer and associated clinical outcomes.
 
Arielle J Medford
Consulting or Advisory Role - AstraZeneca; Guardant Health; Illumina; Myriad Genetics
Speakers' Bureau - Natera
Research Funding - AstraZeneca; Natera
 
Andrzej Niemierko
No Relationships to Disclose
 
Rachel Occhiogrosso Abelman
No Relationships to Disclose
 
Nicholas Haradhvala
Consulting or Advisory Role - MorphoSys
 
Justine Knape
No Relationships to Disclose
 
Laura Spring
Consulting or Advisory Role - AstraZeneca; Daiichi Pharma; G1 Therapeutics; Lilly; Novartis; Precede Bio; Seagen
Research Funding - Genentech/Roche; Gilead Sciences; Lilly; Merck (Inst)
 
Gad Getz
Stock and Other Ownership Interests - Scorpion Therapeutics
Consulting or Advisory Role - Scorpion Therapeutics
Research Funding - IBM; Pharmacyclics
Patents, Royalties, Other Intellectual Property - MSIDetect; MSMuTect; MSMutSig; POLYSOLVER; SignatureAnalyzer-GPU
 
Aditya Bardia
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)